...was CSO and SVP of research at Juno Therapeutics Inc. (NASDAQ:JUNO). Howes was CFO at Heart Metabolics Ltd....

...which will be titrated to maintain target compound plasma levels for 2 8-week dosing periods. Heart Metabolics Ltd....

...$50.0 Aurinia Pharmaceuticals Inc. (TSX:AUP; NASDAQ:AUPH) Immunomodulators for lupus 2/14/14 Private placement of units $52.0 Heart Metabolics Ltd....

...with vehicle. Next steps could include testing CPT1 inhibitors in additional models of cancer-associated cachexia. Heart Metabolics Ltd....

...counsel, CBO, principal financial officer and corporate secretary at Regulus Therapeutics Inc. (NASDAQ:RGLS). Cardiovascular play Heart Metabolics Ltd....

...survival. Next steps could include inhibiting CPT1 or CPT2 in other models of MYC-driven cancer. Heart Metabolics Ltd....

...unit of oxygen. Perhexiline, a generic drug originally indicated for angina, is being pursued by Heart Metabolics Ltd....
...this collaboration are undisclosed. Companies and Institutions Mentioned Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Heart Metabolics Ltd....

...SVP of manufacturing, program management, and clinical operations at Ziopharm Oncology Inc. (NASDAQ:ZIOP). Cardiovascular company Heart Metabolics Ltd....

...Adaptimmune Ltd. and Bellicum Pharmaceuticals Inc. , which are focused on T cell technologies; and Heart Metabolics Ltd....

...Targeted generic Investors in Heart Metabolics Ltd. 's $20 million series A round think the company can use...
...who is chairman of Heart Metabolics, said about 7% of the population are CYP2D6 poor metabolizers. Heart Metabolics...
...company also plans to create a registry to monitor plasma levels in patients taking perhexiline. Heart Metabolics...